Musk and Vivek Ramaswamy — the pharmaceutical mogul and former Republican presidential hopeful — have been picked to lead a ...

Still, you largely own biotech stocks for the promise of their research and development (R&D) pipeline and the company's ...

Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

On Wednesday, Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.21 or 5.66% from the prior close of $3.71. The stock ...

The UK PM Society’s Market Access Interest Group (MAIG) undertook a comprehensive survey on the topic of market access, where it sought the views of both industry and agency. The answers were ...

Investors with a lot of money to spend have taken a bearish stance on Regeneron Pharmaceuticals REGN. And retail traders should know. We noticed this today when the trades showed up on publicly ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...

In the latest quarter, 4 analysts provided ratings for Eton Pharmaceuticals (NASDAQ:ETON), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%.